Text: Small Text  Normal Text  Large Text  Larger Text

    Blog Archive

    PrevPrevApril 2014NextNext

    Canada – European Trade Deal At Risk Due To Controversial Copyright Rules

    PDF  | Print |  E-mail
    Monday July 09, 2012
    Appeared in the Toronto Star on July 8, 2012 as Controversial Copyright Rules Threaten Canada - European Trade Deal

    In October 2007, several leading economies, including the U.S., European Union, and Canada, announced plans to negotiate the Anti-Counterfeiting Trade Agreement (ACTA). Despite being shrouded in secrecy, ACTA details slowly began to emerge, including revelations that lobby groups had been granted privileged access to the draft text as well as leaks that indicated that individual Internet users could be a prime target of new enforcement measures.

    The ACTA talks concluded in 2010, but the controversy over the deal continued to grow. Earlier this year, thousands took the streets in Europe to protest against an agreement that was negotiated in secret and that raised serious concerns about privacy and free speech.

    With public pressure mounting, the European Parliament voted overwhelmingly last week to reject ACTA, striking a major blow to the hopes of supporters who envisioned a landmark agreement that would set a new standard for intellectual property rights enforcement.

    The European Commission, which negotiates trade deals such as ACTA on behalf of the European Union, has vowed to revive the badly damaged agreement. Its most high-profile move has been to ask the European Court of Justice to rule on ACTA's compatibility with fundamental European freedoms with the hope that a favourable ruling could allow the European Parliament to reconsider the issue.

    While the court referral has attracted the lion share of attention, there is an alternate secret strategy in which Canada plays a key role. According to recently leaked documents, the EU plans to use the Canada - EU Trade Agreement (CETA), which is nearing its final stages of negotiation, as a backdoor mechanism to implement the ACTA provisions.

    The CETA IP chapter has already attracted attention due to EU pharmaceutical patent demands that could add billions to provincial health care costs, but the bigger story may be that the same chapter features a word-for-word replica of ACTA. According to the leaked document, dated February 2012, Canada and the EU have already agreed to incorporate many of the ACTA enforcement provisions into CETA, including the rules on general obligations on enforcement, preserving evidence, damages, injunctions, and border measure rules. One of these provisions even specifically references ACTA.

    The EU has also proposed incorporating ACTA's criminal enforcement and co-operation chapters into CETA. The criminal provisions were the target of European Parliament criticism for their lack of proportionality and uncertain application.

    Canada has similarly pushed for the inclusion of ACTA provisions, proposing identical digital lock rules as well as ACTA-style Internet service provider provisions that raised privacy concerns from the European Data Protection Supervisor. In fact, Canada would like to extend ACTA by mandating an anti-camcording provision (a similar provision is currently voluntary in ACTA).

    The European Commission strategy appears to be to use CETA as the new ACTA, burying its provisions in a broader Canadian trade agreement with the hope that the European Parliament accepts the same provisions it just rejected with the ACTA framework. If successful, it would likely then argue that ACTA poses no new concerns since the same rules were approved within the Canadian trade deal.

    The backdoor ACTA approach creates enormous risks for Canada's trade ambitions. Given the huge anti-ACTA movement, the Canada - EU trade deal could face widespread European opposition with CETA becoming swept up in similar protests.

    With anti-ACTA sentiment spreading across Europe, Canada should push to remove the intellectual property chapter from CETA altogether.  The move would not be unprecedented. Many of Canada's free trade agreements feature only limited IP provisions and last year a Canadian parliamentary committee recommended that "domestic copyright policies are not part of any present or future trade negotiations."

    Meanwhile, the U.S. and EU recently announced their own plans to negotiate a trade deal but agreed to keep intellectual property issues out of the talks. If CETA becomes known as ACTA II, the future of the Canada - EU trade deal may hinge on adopting a similar approach.

    Michael Geist holds the Canada Research Chair in Internet and E-commerce Law at the University of Ottawa, Faculty of Law. He can reached at mgeist@uottawa.ca or online at www.michaelgeist.ca.

    , ,
    Share: Slashdot, Digg, Del.icio.us, Newsfeeder, Reddit, StumbleUpon, TwitterTagsShare

    Big Pharma Spending Ratio on Canadian R&D Continues To Decline As IP Demands Increase

    PDF  | Print |  E-mail
    Thursday June 21, 2012
    The large international pharmaceutical companies continue their campaign for new patent rules that the provinces fear will cost taxpayers billions of dollars in additional costs. The lead lobby for the companies, RxD, brought former Prime Minister Brian Mulroney to Ottawa earlier this month to praise reforms from the 1980s that he argued have worked well for Canada. Yet those reforms came with a condition: in return for reforms that granted the companies far stronger patent rights, RxD companies promised to increase their spending on research and development in Canada so that it would rise to 10% of total sales by 1996.

    Now the same companies are lobbying relentlessly for a new round of patent reforms that they say will lead to further growth in research and development. However, a new report from government's Patented Medicines Prices Review Board shows that RxD spending to sales ratio continues a decade-long decline, hitting its lowest level since the 1987 reforms.

    , , ,
    Share: Slashdot, Digg, Del.icio.us, Newsfeeder, Reddit, StumbleUpon, TwitterTagsShare

    Globe on Big Pharma R&D Failure

    PDF  | Print |  E-mail
    Friday June 08, 2012
    The Globe has a terrific masthead editorial today that notes the failure of big pharmaceutical companies to live up to their research and development commitments. It notes that those same companies are now demanding further IP reforms as part of the Canada - EU Trade Agreement.
    , , ,
    Share: Slashdot, Digg, Del.icio.us, Newsfeeder, Reddit, StumbleUpon, TwitterTagsShare

    Provinces Express Concern Over Impact of CETA IP Provisions

    PDF  | Print |  E-mail
    Monday June 04, 2012
    The Canadian Press reports that several provinces have written to the federal government to express concern over the Canada - EU Trade Agreement intellectual property provisions and the potential increase in drug costs that may result. The provinces are demanding compensation of Canada caves to EU demands on drug patents.
    , ,
    Share: Slashdot, Digg, Del.icio.us, Newsfeeder, Reddit, StumbleUpon, TwitterTagsShare
    << Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

    Results 37 - 40 of 81